Global Retirement Partners, LLC Krystal Biotech, Inc. Transaction History

Global Retirement Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jul 14, 2022	BUY	$51.99 - $72.11 $6,498 - $9,013	125 New	125 $7,000
Q4 2021 Jan 21, 2022	SELL	$39.81 - $88.24 $4,976 - $11,030	-125 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$62.14 - $81.82 $4,660 - $6,136	-75 Reduced 37.5%	125 $9,000
Q1 2021 Apr 14, 2021	BUY	$59.42 - $85.46 $4,456 - $6,409	75 Added 60.0%	200 $15,000
Q4 2020 Jan 13, 2021	BUY	$40.64 - $61.38 $5,080 - $7,672	125 New	125 $8,000

275

24.9M

270K

172K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.54B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.